RXR Acquisition Corp. Warrants to purchase Class A common stock
RXRAW
RXRAW was delisted on the 20th of December, 2022.
33 hedge funds and large institutions have $3.37M invested in RXR Acquisition Corp. Warrants to purchase Class A common stock in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$535K |
| 2 |
Goldman Sachs
New York
|
+$146K |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$131K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$123K |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
+$115K |
Top Sellers
RXRAW Hedge Fund Activity: Q2 2021 in Review
33 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in RXR Acquisition Corp. Warrants to purchase Class A common stock (RXRAW) for Q2 2021, worth a combined $3.37M.
Buyers outnumbered sellers: 33 funds opened new RXRAW positions and 0 closed out — a net gain of 33 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Guggenheim Capital, opening a new position worth an estimated $535K.
- 33 institutional investors held RXR Acquisition Corp. Warrants to purchase Class A common stock (RXRAW) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $3.37M of RXR Acquisition Corp. Warrants to purchase Class A common stock stock for Q2 2021.
- 33 funds opened new RXR Acquisition Corp. Warrants to purchase Class A common stock positions in Q2 2021 and 0 closed out, a net change of +33 holders.
- The largest RXR Acquisition Corp. Warrants to purchase Class A common stock buyer in Q2 2021 was Guggenheim Capital, an estimated $535K added.
Based on aggregated 13F filings for Q2 2021.